The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Accumulation of Mutant Huntingtin Fragments in Aggresome-like Inclusion Bodies as a Result of Insufficient Protein Degradation
Open accessAbstract
The huntingtin exon 1 proteins with a polyglutamine repeat in the pathological range (51 or 83 glutamines), but not with a polyglutamine tract in the normal range (20 glutamines), form aggresome-like perinuclear inclusions in human 293 Tet-Off cells. These structures contain aggregated, ubiquitinated huntingtin exon 1 protein with a characteristic fibrillar morphology. Inclusion bodies with truncated huntingtin protein are formed at centrosomes and are surrounded by vimentin filaments. Inhibition of proteasome activity resulted in a twofold increase in the amount of ubiquitinated, SDS-resistant aggregates, indicating that inclusion bodies accumulate when the capacity of the ubiquitin–proteasome system to degrade aggregation-prone huntingtin protein is exhausted. Immunofluorescence and electron microscopy with immunogold labeling revealed that the 20S, 19S, and 11S subunits of the 26S proteasome, the molecular chaperones BiP/GRP78, Hsp70, and Hsp40, as well as the RNA-binding protein TIA-1, the potential chaperone 14–3-3, and α-synuclein colocalize with the perinuclear inclusions. In 293 Tet-Off cells, inclusion body formation also resulted in cell toxicity and dramatic ultrastructural changes such as indentations and disruption of the nuclear envelope. Concentration of mitochondria around the inclusions and cytoplasmic vacuolation were also observed. Together these findings support the hypothesis that the ATP-dependent ubiquitin–proteasome system is a potential target for therapeutic interventions in glutamine repeat disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 2×
“…the involvement of these proteins in signaling pathways as well as their participation in the pathogenesis of neurodegenerative disorders such as Parkinson’s, Alzheimer’s, and Huntington’s disease has also been described (Layfield et al., 1996; Polymeropoulos et al., 1997; Charles et al., 2000;).”
BackgroundTight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“The tetracycline (tet)-regulated system (Gossen and Bujard, 1992) has been used for the expression of Flag-tagged HD exon 1 proteins with 20 (HDQ20), 51 (HDQ51), and 83 (HDQ83) glutamines in 293 Tet-Off cell lines (Figure 1A).”
MethodAmyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Molecular chaperones in cellular protein folding
Hartl, F. U. (1996) · Nature · doi:10.1038/381571a0 · Cited by 3,568
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
Self-citationAggresomes: A Cellular Response to Misfolded Proteins
Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148
Mitochondria as the central control point of apoptosis
Desagher, S., & Martinou, J.-C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01803-1 · Cited by 1,913
Cited by
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
Stefani, M., & Dobson, C. M. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0464-5 · Cited by 1,651
Nishitoh, H., Matsuzawa, A., Tobiume, K., Saegusa, K., Takeda, K., Inoue, K., Hori, S., Kakizuka, A., & Ichijo, H. (2002) · Genes & Development · doi:10.1101/gad.992302 · Cited by 1,338
Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy
Ravikumar, B. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1107 · Cited by 1,111
Modulation of neurodegeneration by molecular chaperones
Muchowski, P. J., & Wacker, J. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1587 · Cited by 1,024
Stress Granule Assembly Is Mediated by Prion-like Aggregation of TIA-1
Gilks, N., Kedersha, N., Ayodele, M., Shen, L., Stoecklin, G., Dember, L. M., & Anderson, P. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-08-0715 · Cited by 996
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Ciechanover, A., & Brundin, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00606-8 · Cited by 982
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
14-3-3 proteins: A historic overview
Aitken, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.005 · Cited by 826
Stress granules and neurodegeneration
Wolozin, B., & Ivanov, P. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0222-5 · Cited by 810
Role of Stress Granules and RNA-Binding Proteins in Neurodegeneration: A Mini-Review
Vanderweyde, T., Youmans, K., Liu-Yesucevitz, L., & Wolozin, B. (2013) · Gerontology · doi:10.1159/000354170 · Cited by 805
Pathways of cellular proteostasis in aging and disease
Klaips, C. L., Jayaraj, G. G., & Hartl, F. U. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709072 · Cited by 798
Proteostasis impairment in protein-misfolding and -aggregation diseases
Hipp, M. S., Park, S.-H., & Hartl, F. U. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.05.003 · Cited by 663
Grune, T., Jung, T., Merker, K., & Davies, K. J. A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.04.020 · Cited by 655
Liu-Yesucevitz, L., Bilgutay, A., Zhang, Y.-J., Vanderwyde, T., Citro, A., Mehta, T., Zaarur, N., McKee, A., Bowser, R., Sherman, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013250 · Cited by 620
Epithelial Endoplasmic Reticulum Stress and Apoptosis in Sporadic Idiopathic Pulmonary Fibrosis
Korfei, M., Ruppert, C., Mahavadi, P., Henneke, I., Markart, P., Koch, M., Lang, G., Fink, L., Bohle, R.-M., Seeger, W., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200802-313oc · Cited by 514
Hsp70 Reduces α-Synuclein Aggregation and Toxicity
Klucken, J., Shin, Y., Masliah, E., Hyman, B. T., & McLean, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400255200 · Cited by 508
Huntington’s Disease: Mechanisms of Pathogenesis and Therapeutic Strategies
Jimenez-Sanchez, M., Licitra, F., Underwood, B. R., & Rubinsztein, D. C. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024240 · Cited by 507
Amm, I., Sommer, T., & Wolf, D. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.031 · Cited by 493
Mateju, D., Franzmann, T. M., Patel, A., Kopach, A., Boczek, E. E., Maharana, S., Lee, H. O., Carra, S., Hyman, A. A., & Alberti, S. (2017) · The EMBO Journal · doi:10.15252/embj.201695957 · Cited by 483
Mechanisms of neurodegeneration in Huntington’s disease
Gil, J. M., & Rego, A. C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06310.x · Cited by 471
Cellular Toxicity of Polyglutamine Expansion Proteins
Schaffar, G., Breuer, P., Boteva, R., Behrends, C., Tzvetkov, N., Strippel, N., Sakahira, H., Siegers, K., Hayer-Hartl, M., & Hartl, F. U. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.06.029 · Cited by 425
Venkatraman, P., Wetzel, R., Tanaka, M., Nukina, N., & Goldberg, A. L. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00151-0 · Cited by 424
Aggresomes Formed by α-Synuclein and Synphilin-1 Are Cytoprotective
Tanaka, M., Kim, Y. M., Lee, G., Junn, E., Iwatsubo, T., & Mouradian, M. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310994200 · Cited by 422
Huntington's disease: from pathology and genetics to potential therapies
Imarisio, S., Carmichael, J., Korolchuk, V., Chen, C.-W., Saiki, S., Rose, C., Krishna, G., Davies, J. E., Ttofi, E., Underwood, B. R., et al. (2008) · Biochemical Journal · doi:10.1042/bj20071619 · Cited by 409
In Situ Structure of Neuronal C9orf72 Poly-GA Aggregates Reveals Proteasome Recruitment
Guo, Q., Lehmer, C., Martínez-Sánchez, A., Rudack, T., Beck, F., Hartmann, H., Pérez-Berlanga, M., Frottin, F., Hipp, M. S., Hartl, F. U., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.030 · Cited by 407
Neckers, L., & Ivy, S. P. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200311000-00003 · Cited by 400
Hassles with Taking Out the Garbage: Aggravating Aggresomes
Garcia‐Mata, R., Gao, Y., & Sztul, E. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.30602.x · Cited by 391
Jung, T., Catalgol, B., & Grune, T. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.04.001 · Cited by 389
Protein aggregates in Huntington's disease
Arrasate, M., & Finkbeiner, S. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.12.013 · Cited by 383
Prefibrillar Amyloid Protein Aggregates Share Common Features of Cytotoxicity
Bucciantini, M., Calloni, G., Chiti, F., Formigli, L., Nosi, D., Dobson, C. M., & Stefani, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400348200 · Cited by 369
Heat shock protein 90: The cancer chaperone
Neckers, L. (2007) · Journal of Biosciences · doi:10.1007/s12038-007-0051-y · Cited by 365
Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway
Yamamoto, A., Cremona, M. L., & Rothman, J. E. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200510065 · Cited by 360
Meriin, A. B., Zhang, X., He, X., Newnam, G. P., Chernoff, Y. O., & Sherman, M. Y. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200112104 · Cited by 359
Protein composition of the intranuclear inclusions of FXTAS
Iwahashi, C. K., Yasui, D. H., An, H.-J., Greco, C. M., Tassone, F., Nannen, K., Babineau, B., Lebrilla, C. B., Hagerman, R. J., & Hagerman, P. J. (2006) · Brain · doi:10.1093/brain/awh650 · Cited by 359
Autophagy in Huntington disease and huntingtin in autophagy
Martin, D. D. O., Ladha, S., Ehrnhoefer, D. E., & Hayden, M. R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2014.09.003 · Cited by 350
In Situ Architecture and Cellular Interactions of PolyQ Inclusions
Bäuerlein, F. J. B., Saha, I., Mishra, A., Kalemanov, M., Martínez-Sánchez, A., Klein, R., Dudanova, I., Hipp, M. S., Hartl, F. U., Baumeister, W., et al. (2017) · Cell · doi:10.1016/j.cell.2017.08.009 · Cited by 349
The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation
Saliba, R. S., Munro, P. M. G., Luthert, P. J., & Cheetham, M. E. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.14.2907 · Cited by 344
The ASK1-MAP Kinase Cascades in Mammalian Stress Response
Matsukawa, J. (2004) · Journal of Biochemistry · doi:10.1093/jb/mvh134 · Cited by 343
Dantuma, N. P., & Bott, L. C. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00070 · Cited by 338
Regulated protein aggregation: stress granules and neurodegeneration
Wolozin, B. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-56 · Cited by 337
Palmitoylation of huntingtin by HIP14is essential for its trafficking and function
Yanai, A., Huang, K., Kang, R., Singaraja, R. R., Arstikaitis, P., Gan, L., Orban, P. C., Mullard, A., Cowan, C. M., Raymond, L. A., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1702 · Cited by 334
The Mechanistic Links Between Proteasome Activity, Aging and Agerelated Diseases
Saez, I., & Vilchez, D. (2014) · Current Genomics · doi:10.2174/138920291501140306113344 · Cited by 325
Lewy-body formation is an aggresome-related process: a hypothesis
Olanow, C. W., Perl, D. P., DeMartino, G. N., & McNaught, K. S. P. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00827-0 · Cited by 305
Roles of molecular chaperones in protein misfolding diseases
Barral, J. M., Broadley, S. A., Schaffar, G., & Hartl, F. U. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2003.12.010 · Cited by 295
Aggregate formation inhibits proteasomal degradation of polyglutamine proteins
Verhoef, L. G. G. C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.22.2689 · Cited by 292
Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors
Lee, H.-J., Shin, S. Y., Choi, C., Lee, Y. H., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105326200 · Cited by 291
Local RNA Translation at the Synapse and in Disease: Figure 1.
Liu-Yesucevitz, L., Bassell, G. J., Gitler, A. D., Hart, A. C., Klann, E., Richter, J. D., Warren, S. T., & Wolozin, B. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4105-11.2011 · Cited by 289
Inefficient degradation of truncated polyglutamine proteins by the proteasome
Holmberg, C. I., Staniszewski, K. E., Mensah, K. N., Matouschek, A., & Morimoto, R. I. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600426 · Cited by 289
Tsai, Y. C., Fishman, P. S., Thakor, N. V., & Oyler, G. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212235200 · Cited by 283
Dry Age-Related Macular Degeneration: Mechanisms, Therapeutic Targets, and Imaging
Bowes Rickman, C., Farsiu, S., Toth, C. A., & Klingeborn, M. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12757 · Cited by 282
Degradation-Mediated Protein Quality Control in the Nucleus
Gardner, R. G., Nelson, Z. W., & Gottschling, D. E. (2005) · Cell · doi:10.1016/j.cell.2005.01.016 · Cited by 280
Aggresome‐related biogenesis of Lewy bodies
McNaught, K. S. P., Shashidharan, P., Perl, D. P., Jenner, P., & Olanow, C. W. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02301.x · Cited by 279
Lysosome trafficking and signaling in health and neurodegenerative diseases
Lie, P. P. Y., & Nixon, R. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.015 · Cited by 269
RNA granules: The good, the bad and the ugly
Thomas, M. G., Loschi, M., Desbats, M. A., & Boccaccio, G. L. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2010.08.011 · Cited by 262
The ubiquitin–proteasome pathway in Parkinson's disease and other neurodegenerative diseases
Ross, C. A., & Pickart, C. M. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.10.006 · Cited by 261
Emerging Role for Autophagy in the Removal of Aggresomes in Schwann Cells
Fortun, J., Dunn, W. A., Joy, S., Li, J., & Notterpek, L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-33-10672.2003 · Cited by 261
Adachi, H., Katsuno, M., Minamiyama, M., Sang, C., Pagoulatos, G., Angelidis, C., Kusakabe, M., Yoshiki, A., Kobayashi, Y., Doyu, M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02203.2003 · Cited by 259
Mulugeta, S., Nguyen, V., Russo, S. J., Muniswamy, M., & Beers, M. F. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0009oc · Cited by 257
Finkbeiner, S. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007476 · Cited by 255
Aulas, A., & Vande Velde, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00423 · Cited by 254
Teuling, E., Ahmed, S., Haasdijk, E., Demmers, J., Steinmetz, M. O., Akhmanova, A., Jaarsma, D., & Hoogenraad, C. C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2661-07.2007 · Cited by 239
Autophagic Stress in Neuronal Injury and Disease
Chu, C. T. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229233.75253.be · Cited by 211
Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson’s disease
McNaught, K. S. P., & Olanow, C. W. (2003) · Annals of Neurology · doi:10.1002/ana.10512 · Cited by 203
Generalized brain and skin proteasome inhibition in Huntington’s disease
Seo, H., Sonntag, K., & Isacson, O. (2004) · Annals of Neurology · doi:10.1002/ana.20207 · Cited by 188
Pathological consequences of VCP mutations on human striated muscle
Hubbers, C. U., Clemen, C. S., Kesper, K., Boddrich, A., Hofmann, A., Kamarainen, O., Tolksdorf, K., Stumpf, M., Reichelt, J., Roth, U., et al. (2007) · Brain · doi:10.1093/brain/awl238 · Cited by 170
Self-citationFunctional genetic analysis of mutations implicated in a human speech and language disorder
Vernes, S. C., Nicod, J., Elahi, F. M., Coventry, J. A., Kenny, N., Coupe, A.-M., Bird, L. E., Davies, K. E., & Fisher, S. E. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl392 · Cited by 167
Synaptic dysfunction in Huntington's disease: a new perspective
Smith, R., Brundin, P., & Li, J.-Y. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5084-5 · Cited by 166
Mechanisms of protein toxicity in neurodegenerative diseases
Chung, C. G., Lee, H., & Lee, S. B. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2854-4 · Cited by 142
Pathological stress granules in Alzheimer’s disease
Ash, P. E. A., Vanderweyde, T. E., Youmans, K. L., Apicco, D. J., & Wolozin, B. (2014) · Brain Research · doi:10.1016/j.brainres.2014.05.052 · Cited by 129
Riguet, N., Mahul-Mellier, A.-L., Maharjan, N., Burtscher, J., Croisier, M., Knott, G., Hastings, J., Patin, A., Reiterer, V., Farhan, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26684-z · Cited by 118
King, M. A., Hands, S., Hafiz, F., Mizushima, N., Tolkovsky, A. M., & Wyttenbach, A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043398 · Cited by 120
Ochaba, J., Monteys, A. M., O’Rourke, J. G., Reidling, J. C., Steffan, J. S., Davidson, B. L., & Thompson, L. M. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.016 · Cited by 94
The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases
Rozpędek-Kamińska, W., Siwecka, N., Wawrzynkiewicz, A., Wojtczak, R., Pytel, D., Diehl, J. A., & Majsterek, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062108 · Cited by 84
Dendritic spine loss and neurodegeneration is rescued by Rab11 in models of Huntington's disease
Richards, P., Didszun, C., Campesan, S., Simpson, A., Horley, B., Young, K. W., Glynn, P., Cain, K., Kyriacou, C. P., Giorgini, F., et al. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.127 · Cited by 82
Huntingtin inclusion bodies are iron‐dependent centers of oxidative events
Firdaus, W. J. J., Wyttenbach, A., Giuliano, P., Kretz‐Remy, C., Currie, R. W., & Arrigo, A. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05537.x · Cited by 71
Discovering the 3′ UTR-mediated regulation of alpha-synuclein
Marchese, D., Botta-Orfila, T., Cirillo, D., Rodriguez, J. A., Livi, C. M., Fernández-Santiago, R., Ezquerra, M., Martí, M. J., Bechara, E., Tartaglia, G. G., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1048 · Cited by 45
Navarro-Yepes, J., Anandhan, A., Bradley, E., Bohovych, I., Yarabe, B., de Jong, A., Ovaa, H., Zhou, Y., Khalimonchuk, O., Quintanilla-Vega, B., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9414-9 · Cited by 37
The Cytotoxicity and Clearance of Mutant Huntingtin and Other Misfolded Proteins
Folger, A., & Wang, Y. (2021) · Cells · doi:10.3390/cells10112835 · Cited by 32
“On the other hand, proteasome inhibitors increase the level of mutant Htt, accelerating the formation of inclusion bodies [70].”
BackgroundStrategies to Investigate Ubiquitination in Huntington's Disease
Sap, K. A., & Reits, E. A. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00485 · Cited by 25
Cellular maintenance of nuclear protein homeostasis.
Gallagher, P. S., Oeser, M. L., Abraham, A.-C., Kaganovich, D., & Gardner, R. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1530-y · Cited by 22
Docosahexaenoic acid impairs the maturation of very low density lipoproteins in rat hepatic cells
Maitin, V., Andreo, U., Guo, L., & Fisher, E. A. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m043026 · Cited by 14
Characterization of Growth Suppressive Functions of a Splice Variant of Cyclin D2
Wafa, K., MacLean, J., Zhang, F., & Pasumarthi, K. B. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053503 · Cited by 14
Metadata
- Authors
- Waelter, S., Boeddrich, A., Lurz, R., Scherzinger, E., Lueder, G., Lehrach, H., & Wanker, E. E.
- Venue
- Molecular Biology of the Cell
- Published
- 2001-05
- Volume
- 12
- Issue
- 5
- Pages
- 1393-1407
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- OpenAlex
- W2056867819
- Cited by
- 631
- References
- 56
- FWCI
- 14.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.